Munafa Stock Market Course + Intraday & FNO calls 
Citius Pharmaceuticals (CTXR) Technical (Analysis) Reports Citius Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Citius Pharmaceuticals (CTXR)
Technical Analysis Report for USA stock CTXR Citius Pharmaceuticals. Dated: 01 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CTXR Citius Pharmaceuticals then click here. or read Experts views on Citius Pharmaceuticals or Forecast & share price targets of Citius Pharmaceuticals
Citius Pharmaceuticals Opened at 0.69 and Closed at: 0.70, which is 0% of previous session's close. It moved within a range of 0.65 and 0.72
The session was a Bullish session with an average volume of 864100, which is -71.15% of previous session's volumes.
A Dead cross was found 4 days back on short term averages
A Dead cross was found 2 days back on mid term averages
Support for tomorrow is 0.68 and resistance for tomorrow is 0.75
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.66, 0.62 resistance for tomorrow's hourly charts is 0.73, 0.76
10 Day SMA for Citius Pharmaceuticals (CTXR) is 0.76 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Citius Pharmaceuticals (CTXR) is 0.8 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Citius Pharmaceuticals (CTXR) is 0.79 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.84 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Citius Pharmaceuticals is 1.08 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Citius Pharmaceuticals is at 0.8 and 200 DMA is at 1.08, while 50 DMA and 100 DMA are at 0.79 and 0.84 respectively
Citius Pharmaceuticals (CTXR) moving average of 20 SMA is at 0.8 and 20 EMA is at 0.75
| Date | Closing Price | 20 SMA | 20 EMA |
| 01 Fri May | 0.70 | 0.8 | 0.75 |
| 30 Thu Apr | 0.70 | 0.81 | 0.76 |
| 29 Wed Apr | 0.60 | 0.81 | 0.77 |
| 28 Tue Apr | 0.65 | 0.83 | 0.79 |
| 27 Mon Apr | 0.70 | 0.83 | 0.81 |
| 24 Fri Apr | 0.75 | 0.83 | 0.82 |
Citius Pharmaceuticals (CTXR) moving average of 50 SMA is at 0.79 and 50 EMA is at 0.79
| Date | Closing Price | 50 SMA | 50 EMA |
| 01 Fri May | 0.70 | 0.79 | 0.79 |
| 30 Thu Apr | 0.70 | 0.79 | 0.79 |
| 29 Wed Apr | 0.60 | 0.79 | 0.79 |
| 28 Tue Apr | 0.65 | 0.8 | 0.8 |
| 27 Mon Apr | 0.70 | 0.8 | 0.81 |
| 24 Fri Apr | 0.75 | 0.8 | 0.81 |
Citius Pharmaceuticals (CTXR) moving average of 100 SMA is at 0.84 and 100 EMA is at 0.92
| Date | Closing Price | 100 SMA | 100 EMA |
| 01 Fri May | 0.70 | 0.84 | 0.92 |
| 30 Thu Apr | 0.70 | 0.85 | 0.92 |
| 29 Wed Apr | 0.60 | 0.85 | 0.92 |
| 28 Tue Apr | 0.65 | 0.86 | 0.93 |
| 27 Mon Apr | 0.70 | 0.87 | 0.94 |
| 24 Fri Apr | 0.75 | 0.87 | 0.94 |
Citius Pharmaceuticals (CTXR) moving average of 200 SMA is at 1.08 and 200 EMA is at 1.17
| Date | Closing Price | 200 SMA | 200 EMA |
| 01 Fri May | 0.70 | 1.08 | 1.17 |
| 30 Thu Apr | 0.70 | 1.09 | 1.17 |
| 29 Wed Apr | 0.60 | 1.09 | 1.17 |
| 28 Tue Apr | 0.65 | 1.1 | 1.18 |
| 27 Mon Apr | 0.70 | 1.1 | 1.19 |
| 24 Fri Apr | 0.75 | 1.11 | 1.19 |
Novo Nordisk has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Novo Nordisk, about 38.29% more returns!
Zai Lab has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Zai Lab, about 23.67% more returns!
Viking Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Viking Therapeutics, about 6.91% more returns!
Sintx Technologies has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Sintx Technologies, about 13.86% more returns!
Phio Pharmaceuticals has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 9.08% more returns!
Outlook Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Outlook Therapeutics, about 48.6% more returns!
Microbot Medical has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Microbot Medical, about 7.21% more returns!
Lifevantage Corporation has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Lifevantage Corporation, about 48.5% more returns!
Kura Oncology has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Kura Oncology, about 21.66% more returns!
Galectin Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 7.27% more returns!
Ensign Group has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Ensign Group, about 11.4% more returns!
Crispr Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 23.69% more returns!
Bioxcel Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Bioxcel Therapeutics, about 23.86% more returns!
Biocryst Pharmaceuticals has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Biocryst Pharmaceuticals, about 15.64% more returns!
Autolus Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 23.6% more returns!
Amneal Pharmaceuticals has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Amneal Pharmaceuticals, about 22.49% more returns!
Allogene Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 1.29% more returns!
Akebia Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Akebia Therapeutics, about 24.66% more returns!
Citius Pharmaceuticals Technical analysis of indicators
Price action analysis of Citius Pharmaceuticals (CTXR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Citius Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Citius Pharmaceuticals in short term and the sell signal is strong.
Citius Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Citius Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Citius Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.76 and Citius Pharmaceuticals CTXR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Citius Pharmaceuticals CTXR stock. Volume based technical analysis of Citius Pharmaceuticals CTXR stock is negative.
Citius Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CTXR Citius Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CTXR Experts View which covers a lot of information including buying and selling signals
CTXR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Citius Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Citius Pharmaceuticals (CTXR) Technical (Analysis) Reports Citius Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
